Medicine/Health

Potential Treatment for Chronic Kidney Disease in Dogs Revealed

Potential Treatment for Chronic Kidney Disease in Dogs Revealed

20 March, 2025

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in Journal of Veterinary Internal Medicine, offers new hope for the management of chronic kidney disease (CKD) in dogs. The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical complications of CKD.


 

Lung Cancer Research Foundation Announces Research Collaboration with Israel Cancer Research Fund Groups partner on research project to test innovative new treatment for KRAS-mutant cancer being developed at Hebrew University

Lung Cancer Research Foundation Announces Research Collaboration with Israel Cancer Research Fund Groups partner on research project to test innovative new treatment for KRAS-mutant cancer being developed at Hebrew University

19 February, 2025

The Lung Cancer Research Foundation (LCRF) is pleased to announce its partnership with Israel Cancer Research Fund (ICRF) on a project led by Joel Yisraeli, PhD, and his lab in the Department of Developmental Biology and Cancer Research at the Hebrew University of Jerusalem. The ICRF-LCRF Project Grant is a three-year, $180,000 award.


 

Innovative Training Program Equips Clinicians to Treat Trauma and Severe Mental Health Conditions

Innovative Training Program Equips Clinicians to Treat Trauma and Severe Mental Health Conditions

29 January, 2025

A three-year CBT and CPT training program led by Hebrew University and the Israeli Ministry of Health has successfully equipped over 100 public health clinicians with evidence-based tools to treat individuals with serious mental health conditions and trauma survivors. This milestone enhances mental health accessibility and builds a sustainable framework for effective mental healthcare across Israel.